The global prosthetic heart valve market size was US$ 6.9 billion in 2021. The global prosthetic heart valve market size is forecast to reach US$ 19.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period from 2022 to 2030.

A prosthetic heart valve, also known as an artificial heart valve, is implanted in the heart of someone who has the cardiac vascular disease (valvular heart disease). The prosthetic valve is made of robust material like carbon or titanium. The three types of prosthetic heart valves are mechanical heart valves, transcatheter heart valves, and tissue or bio-prosthetic heart valves. In addition, individuals can choose a prosthesis based on their health status and their surgeon's recommendations. Additionally, heart valve replacement involves removing the diseased valve and replacing it with an artificial one.

Factors Influencing Market Growth
The rising burden exerted by valvular heart diseases, the growing geriatric population, the turn towards a sedentary lifestyle of people, novel advances in heart valves, increasing awareness regarding surgical treatment choices, and the rise in demand for minimally invasive surgeries drive the global market.
Technical advances in prosthetic heart valves lead to the production of compatible, long-lasting, cost-effective invasive devices to fuel the global market growth.
The increased cost of prosthetic heart valves and the availability of alternative choices for treating heart valve disease may slow down the overall market growth.

Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global prosthetic heart valve market. Several governments worldwide imposed a lockdown in order to prevent the spread of the deadly virus. This postponed the surgical procedure required for establishing prosthetic heart valves and prosthetic heart valve manufacturing for up to six months.
Yet, the need for prosthetic heart valves increased as the people suffering from the virus encountered asthma and cardiovascular disorders as an aftereffect of the contamination directed to gradual market growth.

Regional Analysis
North America garnered a significant market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing medical expertise, unique product launches, and government laws that offer easy access to the production & supervision of cardiac valve devices. In addition, the increasing prevalence of lifestyle diseases such as diabetes and obesity. Thus, these factors are likely to boost the market growth in the region.

The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing prevalence of cardiac disorders like aortic stenosis, the expansion of healthcare infrastructure in countries like China and India. In addition, the continuous emphasis on market players to invest in emerging industries. Therefore, these factors drive the market growth in the region.

Leading Competitors
The leading prominent companies profiled in the global prosthetic heart valve market are:
Abbott
Medtronic
Meril Life Sciences Pvt. Limited
Boston Scientific Corporation
Micro Interventional Devices, Incorporated
Direct Flow Medical, Incorporated
Edwards Lifesciences Corporation
LivaNova PLC
JenaValve Technology, Incorporated
CryoLife, Incorporated
Other Prominent Players

Scope of the Report
The global prosthetic heart valve market segmentation focuses on Product and Region.
Segmentation based on Product
Mechanical Heart Valve
Tissue Heart Valve
Transcatheter Heart Valve
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Prosthetic Heart Valve Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Prosthetic Heart Valve Market is projected to reach US$ 19.7 billion by end of 2030 from US$ 6.9 billion in 2021, at a CAGR of 11.1%
Meta Keywords: prosthetic heart valve market Size, prosthetic heart valve market share, prosthetic heart valve market trend, prosthetic heart valve market Forecast, prosthetic heart valve market insight